{ "cik": 1658247, "cik_padded": "0001658247", "entityName": "Crinetics Pharmaceuticals, Inc.", "fiscal_years": [ { "accn": "0001658247-26-000012", "filed": "2026-02-26", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 5762000.0, "cash": 101536000.0, "eps_diluted": -4.95, "free_cash_flow": -383684000.0, "net_income": -465317000.0, "operating_cash_flow": -377922000.0, "operating_income": -516769000.0, "revenue": 7696000.0, "stockholders_equity": 992083000.0, "total_assets": 1126257000.0, "total_liabilities": 134174000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.13524473254757918, "revenue_growth_yoy": 6.407122232916266, "roa_avg2y": -0.3634083852659801, "roa_period_end": -0.41315348095505733, "roe_avg2y": -0.40167414221144915, "roe_period_end": -0.4690303129879254 } }, { "accn": "0001658247-26-000012", "filed": "2026-02-26", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 3844000.0, "cash": 264545000.0, "eps_diluted": -3.69, "free_cash_flow": -234038000.0, "net_income": -298408000.0, "operating_cash_flow": -230194000.0, "operating_income": -338854000.0, "revenue": 1039000.0, "stockholders_equity": 1324805000.0, "total_assets": 1434592000.0, "total_liabilities": 109787000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.08287030921531847, "revenue_growth_yoy": -0.74109145277847, "roa_avg2y": -0.2883245690102877, "roa_period_end": -0.20800896700943544, "roe_avg2y": -0.32019554581737003, "roe_period_end": -0.22524673442506632 } }, { "accn": "0001658247-26-000012", "filed": "2026-02-26", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 4688000.0, "cash": 54897000.0, "eps_diluted": -3.69, "free_cash_flow": -173286000.0, "net_income": -214529000.0, "operating_cash_flow": -168598000.0, "operating_income": -222608000.0, "revenue": 4013000.0, "stockholders_equity": 539106000.0, "total_assets": 635353000.0, "total_liabilities": 96247000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.1785307527647624, "roa_avg2y": -0.43447635461844664, "roa_period_end": -0.3376532415838124, "roe_avg2y": -0.501567625322351, "roe_period_end": -0.3979347289772327 } }, { "accn": "0001658247-26-000012", "filed": "2026-02-26", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1656000.0, "cash": 32672000.0, "eps_diluted": -3.15, "free_cash_flow": -116861000.0, "net_income": -163918000.0, "operating_cash_flow": -115205000.0, "operating_income": -167882000.0, "stockholders_equity": 316328000.0, "total_assets": 352176000.0, "total_liabilities": 35848000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.11332540906906755, "roa_avg2y": -0.46621188268905606, "roa_period_end": -0.46544341465630823, "roe_avg2y": -0.505707480810524, "roe_period_end": -0.518189980020738 } }, { "accn": "0000950170-25-029050", "filed": "2025-02-27", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 436000.0, "cash": 200695000.0, "eps_diluted": -2.8, "free_cash_flow": -89024000.0, "net_income": -107641000.0, "operating_cash_flow": -88588000.0, "operating_income": -107702000.0, "stockholders_equity": 331944000.0, "total_assets": 351015000.0, "total_liabilities": 19071000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.0574524618610368, "roa_avg2y": -0.40280282902368747, "roa_period_end": -0.3066564106946997, "roe_avg2y": -0.42982212700878286, "roe_period_end": -0.32427457643457935 } }, { "accn": "0000950170-24-022108", "filed": "2024-02-28", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 186000.0, "cash": 93087000.0, "eps_diluted": -2.42, "free_cash_flow": -62213000.0, "net_income": -73812000.0, "operating_cash_flow": -62027000.0, "operating_income": -74953000.0, "revenue": 71000.0, "stockholders_equity": 168919000.0, "total_assets": 183445000.0, "total_liabilities": 14526000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.08599387872293822, "revenue_growth_yoy": -0.9404861693210393, "roa_avg2y": -0.4704067911108845, "roa_period_end": -0.40236583172067925, "roe_avg2y": -0.5160631759992729, "roe_period_end": -0.43696683025592153 } }, { "accn": "0001564590-21-016719", "filed": "2023-02-28", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 492000.0, "cash": 40326000.0, "free_cash_flow": -46873000.0, "net_income": -50422000.0, "operating_cash_flow": -46381000.0, "operating_income": -53832000.0, "revenue": 1193000.0, "stockholders_equity": 117139000.0, "total_assets": 130377000.0, "total_liabilities": 13238000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.11301103816832993, "revenue_growth_yoy": -0.5086490939044481, "roa_avg2y": -0.3341506733114198, "roa_period_end": -0.3867399924833368, "roe_avg2y": -0.36357998875124387, "roe_period_end": -0.4304458805350908 } }, { "accn": "0001564590-21-016719", "filed": "2022-03-30", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1059000.0, "cash": 44973000.0, "free_cash_flow": -20518000.0, "net_income": -27115000.0, "operating_cash_flow": -19459000.0, "operating_income": -28710000.0, "revenue": 2428000.0, "stockholders_equity": 160225000.0, "total_assets": 171415000.0, "total_liabilities": 11190000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.0698392885005461, "revenue_growth_yoy": 0.18728606356968217, "roa_avg2y": -0.28997984097362217, "roa_period_end": -0.15818335618236443, "roe_avg2y": -0.37347713201517874, "roe_period_end": -0.16923076923076924 } }, { "accn": "0001564590-21-016719", "filed": "2021-03-30", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 304000.0, "cash": 14192000.0, "free_cash_flow": -9783000.0, "net_income": -9157000.0, "operating_cash_flow": -9479000.0, "operating_income": -9127000.0, "revenue": 2045000.0, "stockholders_equity": -15022000.0, "total_assets": 15598000.0, "total_liabilities": 920000.0 }, "period_end": "2017-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "revenue_growth_yoy": 2.4719864176570456, "roa_period_end": -0.5870624439030645, "roe_avg2y": 0.862809761613116 } }, { "accn": "0001564590-20-009365", "filed": "2020-03-09", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD" }, "fundamentals": { "capex": 190000.0, "free_cash_flow": -5658000.0, "net_income": -6019000.0, "operating_cash_flow": -5468000.0, "operating_income": -6044000.0, "revenue": 589000.0, "stockholders_equity": -6204000.0 }, "period_end": "2016-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001658247-26-000012", "filed": "2026-02-26", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001658247.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001658247.json" }, "ticker": "CRNX" }